Related references
Note: Only part of the references are listed.Cannabinoids in the management of difficult to treat pain
Ethan Russo
Therapeutics and Clinical Risk Management (2016)
A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex® (nabiximols)
W. Notcutt et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols (Sativex®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis
A. Novotna et al.
EUROPEAN JOURNAL OF NEUROLOGY (2011)
New Insights in the Pathophysiology and Treatment of Multiple Sclerosis Spasticity and Related Symptoms
Xavier Montalbán
Expert Review of Neurotherapeutics (2011)
Retrospective observational study of the management of multiple sclerosis patients with resistant spasticity in Spain: the '5E' study
Rafael Arroyo et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2011)
Rehabilitation in practice Spasticity management
V. L. Stevenson
CLINICAL REHABILITATION (2010)
Meta-analysis of the efficacy and safety of Sativex (nabiximols), on spasticity in people with multiple sclerosis
Derick T. Wade et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis
C. Collin et al.
NEUROLOGICAL RESEARCH (2010)
Validity, reliability, and clinical importance of change in a 0-10 numeric rating scale measure of spasticity: A post hoc analysis of a randomized, double-blind, placebo-controlled trial
John T. Farrar et al.
CLINICAL THERAPEUTICS (2008)
Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis
C. Collin et al.
EUROPEAN JOURNAL OF NEUROLOGY (2007)
Endocannabinoids and the regulation of their levels in health and disease
Vincenzo Di Marzo et al.
CURRENT OPINION IN LIPIDOLOGY (2007)
Cannabinoid pharmacology: the first 66 years
RG Pertwee
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis
D. T. Wade et al.
MULTIPLE SCLEROSIS JOURNAL (2006)
Cannabis use in patients with multiple sclerosis
M. S. Chong et al.
MULTIPLE SCLEROSIS JOURNAL (2006)
Combined cannabinoid therapy via an oromucosal spray
Jordi Perez
DRUGS OF TODAY (2006)
Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients
DT Wade et al.
MULTIPLE SCLEROSIS (2004)
Prevalence and treatment of spasticity reported by multiple sclerosis patients
MA Rizzo et al.
MULTIPLE SCLEROSIS (2004)
Share Paper
